Main content
This episode will be available soon

Drug Prices in Developing Countries

The pharmaceutical industry and the price of drugs in the developing world

GlaxoSmithKline has announced price-cuts for drugs in the developing world. An interview with CEO of the company, Andrew Witty.
Also: Yusuf Hamied, head of generic drugs company Cipla, and Mogha Kamal-Yanni, HIV policy advisor at Oxfam, give their reaction to Andrew Witty's announcement and their opinions on patenting medicines.
HPV vaccination to be provided at cost in Africa by drug company Merck.

26 minutes

More episodes

See all episodes from Health Check

Podcast

  • Health Check

    Health issues and medical breakthroughs from around the world.